Company news

Bionano Genomics, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Bionano Genomics Expands Its Diagnostic Testing Menu with Launch of Lineagen’s EpiPanelDx PLUS Gene Panel Test that Identifies Genetic Conditions Related to Epilepsy

September 13, 2020

Bionano Genomics Announces Continued Expansion of European Business With Adoption of Saphyr at Three of Europe’s Largest Pediatric Hospitals in Spain, Italy and France

September 9, 2020

Bionano Genomics Announces Adjournment of Special Meeting of Stockholders to September 29, 2020

August 30, 2020

Bionano Genomics Appoints Tech Executive Christopher Stewart as its Chief Financial Officer to Help Manage, Grow and Expand Bionano’s Global Business

August 25, 2020

Bionano Genomics Acquires Diagnostics Services Provider Lineagen, Inc. to Accelerate Clinical Adoption of Saphyr for Digital Cytogenetics

August 23, 2020

Bionano Saphyr Services Offered in CLIA Certified Lab Expands Bionano Genomics’ Clinical Applications

August 19, 2020

Bionano Genomics Appoints Industry Leading Cytogeneticist Dr. Alka Chaubey as the Company’s First Chief Medical Officer to Help Lead the Conversion of Cytogenetics to Digital Cytogenetics with Saphyr

August 17, 2020

Bionano Genomics Announces “At-The-Market” Equity Program

August 16, 2020

Bionano Genomics Reports Second Quarter 2020 Financial Results and Provides Business Update

August 12, 2020

Bionano Genomics to Report Second Quarter 2020 Financial Results and Host a Conference Call and Webcast on August 13

August 6, 2020

Bionano Genomics Solidifies its Entry into Solid Tumor Analysis with Launch of New Kit and Protocol that Significantly Simplify Tissue and Solid Tumor Analysis

July 8, 2020

Bionano Genomics Reports First Quarter 2020 Financial Results and Provides Business Update

June 17, 2020

Bionano Genomics Announces Issuance of US Patent for Combined Nanochannel-Nanopore Device

June 7, 2020

Bionano Genomics to Report First Quarter 2020 Financial Results on June 18, 2020

May 13, 2020

Bionano Genomics announces pricing of $18 million underwritten public offering

April 1, 2020

Three Top European Sites Adopt Bionano Saphyr® for Cancer, Genetics, and Cytogenetic Applications

March 22, 2020

Bionano Genomics Reports Fourth Quarter and Year End 2019 Financial Results and Provides Business Update

March 4, 2020

Bionano Genomics to Report Fourth Quarter and Year End 2019 Financial Results and Host a Conference Call and Webcast on March 5

February 27, 2020

Bionano Genomics Releases Saphyr Updates for Industry-Leading Data Yields that Enable Analysis of Complex Cancer Samples at Unprecedented Depths

February 23, 2020

Bionano Genomics’ Saphyr® System is Adopted by GeneDx for the Clinical Detection of Genetic Variants in Muscular Dystrophies, Developmental and Reproductive Disorders

January 5, 2020

Bionano Genomics Reports Third Quarter 2019 Financial Results and Provides Business Update

November 6, 2019

Bionano Genomics Announces Pricing of $18 Million Underwritten Public Offering

October 20, 2019

Bionano Genomics Announces Adoption of Its Saphyr® System by Clinical Cytogenetics Groups in Academia and Industry to Replace Traditional Methods for Clinical Testing

October 15, 2019

← Newer news releases

Calls

The 5 newest of 24 calls. Every call is listed under its year.

Decks

The 5 newest of 18 decks. Every deck is listed under its year.